Katy Tobin, Sinead Maguire, Bernie Corr, Charles Normand, Orla Hardiman, Miriam Galvin Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative condition with a mean life expectancy of 3 years from first symptom. Understanding the factors that are...
van Eijk RPA, Kliest T, McDermott CJ, Roes KCB, Van Damme P, Chio A, Weber M, Ingre C, Corcia P, Povedano M, Reviers E, van Es MA, Al-Chalabi A, Hardiman O, van den Berg LH. https://doi.org/10.1080/21678421.2020.1788092 A change in our current approach toward drug...
Meimei Yang, Min Liu, Yicheng Ding, Alice Vajda, Jun Ma, Huixian Cui, Timothy O’Brien, David Henshall, Orla Hardiman, Sanbing Shen https://doi.org/10.1016/j.scr.2020.101752 The majority of amyotrophic lateral sclerosis are sporadic (sALS) with no familial...
Anna Markella Antoniadi, Miriam Galvin, Mark Heverin, Orla Hardiman, Catherine Mooney http://dx.doi.org/10.1136/bmjopen-2019-033109 Objectives Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative disease that is characterised by the rapid degeneration of...
Martin Crivello, Marion C. Hogg, Elisabeth Jirström, Luise Halang, Ina Woods, Megan Rayner, Karen S. Coughlan, Sebastian A. Lewandowski, Jochen H. M. Prehn https://doi.org/10.1242/dmm.040238 Amyotrophic lateral sclerosis (ALS) presents a poorly understood...
